You are on page 1of 76

-3

GVG , 2011 3 22

Gesellschaft fur Versicherungswissenschaft und -gestaltung e.V. (GVG)


Hansaring 43, 50670 Cologne, Germany
Tel.: +49/221/91286717, Fax: +49/221/91286759
e-mail: m.wrede@gvg-koeln.de
www.gvg-koeln.de


1.

2. ,

3. ,

4.

5.

/
5.1 -2009 4- 9- 108
2009-2010 ,
,
5.2

5.3

6.


7.
,


:
: ,

: , ,

8
14
14
15
15
16
16
18
18
19
20
21

8.

23

9.

26

1.1 - , 27
1.2 ,

30

1.3

31

2. , ,
2
3.

39

4.

63

5.

67

33

NLM

Norwegian Lutheran Mission

VSO

Volunteer Service Overseas

1.
()
.
- ,
.
. -
.
,
.
-
. -
. ,
(

). , ,
.
.
1- 6:
, , , ,
, ,
()
6.1- .
. -
, ,
, 6.2-
.
1- 5 /
: 1.1:

-
. .
1- 17: ()
: - , , ,
. 1-
10: , 10.1:
-
- .
1- 17: - ,
, , ,
- . -
, , -
. 1- 20:
20.1., 20.2., 20.3- .
.
4

2006-2010
4- 13
, , ,
: 13.1. , ,
, ,
.
2.

1992 , .
,
10
. , ,
.
2005 -

. ()
. - -
2000 4 -
. -2
- 6 2007 .
2006 ,
, , ,
. - .
,
. , ,
,
. , ,
7000-40000
.
,
.
. ,
. ,
,
.
, , ,
, , , , ,
, ,
.
, ,
.

3. ,

2 . :
1. ,
2.
,
, ( ,
). 6.2-
, , ,
. 9.2-
, ,
, , , ,
, ,
.
www.estandart.mn
5600 ,
200 .
.
, ,
, .
.
, ,
, 3
.
4.

()
, , ,
.
, EPOS () ,
. 1- 1-3-
. - 2, 3-
,
.


. , ,
.
.
/ - -
.
6

.

.
-
.
- 2009 108
2, 3-
.
.
- 1.1 1.3- . 2010
-
.
-3 , GVG
- , .
- ,
.
, , - .
- 2010 1- Dutch College of
General Practitioners- , (Geraets JJ, et al
2010).
.
- .
2 . :
1: -
. -
.
- .
2: -
.

- .
. , .
/
.
.
,
. -
,
.

1.
, /
.
;

.
.
, , ,
(Lugtenberg M, 2010).
Lugtenberg
, -
.
, ( ) .
-
.
-
.
-
(Lugtenberg M, et al 2010).
Lugtenberg-
. - ,
.
.

5.

5.1 - 2009 4- 9- 108


2009-2010 , ,



1
,

2
,
,
3


,
,

2009 - 2

2010 - 2

2009 - 4

2010 , 4-

2009 , 4-

6
7

10 ,
11 ,
12
13

14
,
15
16
17

9

, ,
, II
, ,
-

2009-1
2010 1

2009, 4-

2010, 4-

2009. III

-
-
-

2009. III
2010. I
2009. III

2009. III

-
-
-

2009. IV
2009. III
2010. I

18



19



20
()
21
()
22
()
23
()
24
()
25
()
26
()
27
()

28

29

30

31

32

33


34
,

35
,


36


37
,

38
,

39
,
40
,

41



42

43

44

45

46

47

10

2009. IV

2010. I

-
-
-
-
-
-
-
-

2009. III
2009. III
2009. IV
2009. IV
2010. I
2010. I
2010. II
2010. II

-
-
-
-
-
-

2009. III
2009. III
2009. III
2009. III
2009. III
2009. III

2010. II

2010. II

2009. III

2009. III

2009. III

-
-

2010. I
2010. I

-
-

2009. IV
2009. IV

-
-

2009. III
2009. III

-
-
-
-

2009. III
2009. III
2010. I
2010. I

48


-
2010. I

49

-
2010. I


50
,
-
2009. III
51
,
-
2009. III

52

-
2009. III
53

-
2009. III
54

-
2010. I
55

-
2010. I

56
()
-
2009. III

57
()
-
2009. III

58

-
2010. I


59

-
2009. III

60

-
2009. III

61

-
2009. III

62

-
2009. III

63
0-3

2009-1
64

2009-2

65

2009-1
66

2009-2
,
67
,
,
2009-1

68

2009-1
69

2009-1
70

2009-1
71

2009-1
72

2009-1
73

2009-1
74

2009-1
75

2009-1
76

2009-1
77

2009-1
11

78
79
80

D
E

81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107


, ,

108
, ,

109
, ,

110
, ,

111
,
,
112
,
,
113
, ,

114
, ,


12

2009-1
2009-1
2009-1

2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-1
2009-2
2009-2
2009-2
2009-2
2009-2
2009-2
2009-2
2009-1
2009-1
2008-2

2008-2

2008-2

2008-2

2008-4

2008-4

2008-2

2008-3

115

,

116
,

117


118

119
,
120
,

121
,

122
,
123
,
124
,

125
,

126
,
127
,
128
,

129
,
130
,
131
, , ,

132
,
133
,

134

,
135
,
136
,

137
,
138
,

139
,

140
,


141
,
142
,
143

13

2009

2009

2009

2009-1
2009-2
2009-2

2009 2

2009-2
2009-2
2009-2

2009-3

2009-3
2009-3
2009-3

2009-3
2009-4
2009-4

2009 4
2010 1

2010 1

2010-1
2010 2

2010 2
2010 2

2010-3

2010 3

2010 2
2010 2
2010 2

144


,
145

,
146

,
147


148
,
149
,
150
,

151

2010-2

2010-2

2010 2

2010-3

2009-1
2009-1
2010-2

2010-2

5.2.


,

,
,


-
-

-3
US$ 1000

HSDP-3
US$ 1000


-3

-3

-3

-3

-3

-3

5.3.

Name of standards/guidelines

Responsible
Who should develop
organization

-3


-
-

14

Funding organization
-3


-
-

- : - , -
.

-
- .
-
- /
.
-
.
6.

2
. :
-

, .

.
.
, , ,
. .

-
.
. :

()
, 2003
, , 2006

-
.
-
. . -
. -
15


.
:
-


. -
.
, .
, , .
,
.
- ,
, -
.
, , 3-6
.

7.

. - ,
.
- , ,
.
-

:
(http://www.who.int/making_pregnancy_safer/documents/clinical_guidelines/en/index.html)
- ,
,
. - , ,
, , .
,
.
. MIMS VIDAL

,
. .
: Cochrane collaboration- Systematic review
/ Meta analysis
. .

. .

.
16


. , - - -
. ,
NICE (
National Institute for Health and Clinical Excellence), SIGN (Scottish intercollegiate guidelines
network)- - .
.

American Association for Family
Medicine/Practice AAFP-

Australian stroke foundation-



National Health
and Medical Research Council-

Cochrane
Embase
Guidelines international network
Health InterNetwork Access to Research
Initiative (HINARI).
,
.
National Institute for Clinical Excellence
(NICE),
PubMed/NLM Medline
SIGN, Scottish Intercollegiate Guidelines
Network
The Therapeutics initiative
- Department of Health, National
Heart, Lung and Blood Institute-

http://www.aafp.org/online/en/home/clinical/clinicalrecs.html

http://www.strokefoundation.com.au/news/welcome/clinical-guidelinesfor-acute-stroke-management
http://www.nhmrc.gov.au/publications/subjects/clinical.htm;
http://www.clinicalguidelines.gov.au/

http://www.cochrane.org/reviews/
http://embase.com/info/
http://www.g-i-n.net/

http://www.who.int/hinari/en/

http://www.nice.org.uk/aboutnice/howwework/developingniceclinicalguid
elines/clinicalguidelinedevelopmentmethods/clinical_guideline_developm
ent_methods.jsp
http://www.ncbi.nlm.nih.gov/pubmed
http://www.sign.ac.uk/
http://www.sign.ac.uk/guidelines/published/support/index.html
http://www.ti.ubc.ca/

http://www.nhlbi.nih.gov/guidelines/index.htm

-

. British National
Formulary for Adults and children, PDF (Physicians desk reference), - Model Formulary
SPC (Short Product Characteristic Files), European medicine regulatory authority (EMEA), -
17

Food and Drug Administration (FDA), Therapeutics Goods Administration (TGA),


, National Drug Regulatory Authority .

.
American Medical Association (AMA)- 1980 8
. 50
.
10
. , ,
, .

.
- ,
.
.
. -
. -
, .
:

, ,

,
,

,
,

,
,
,


, . -
.
. ,
.
- 8

. :
1. ,
2.
3.
18

4.
5.
6.
7.
8.


.
:
- ,
.
. -
.

. - ,

.
-
. - ,
.
.
.
- (

).
/
.
.
- -

(http://www.wma.net/en/30publications/10policies/b3/index.html)
,
(
).
: ,
.

.
- .
(Canadian Diabetes Association)
- .
19

, -
.
- ()
. (Manas Taalimi
, 2006.,; Shah BR, 2010)
- .
, - .
,
,
. -
2
.
: , ,

, .
- .
.

. ,
, , ,
.



.


.

.
12- , ,
, 30 , , , ,
, , .

.

, .
.
-
(Luckhoff. C, Starr M, 2010).

20

- .
-
, , .
,


.
-

. 8%
. 24 ,

. ,
, . ,
2 .
S. Rajapaksa, M. Starr - .


. S. Rajapaksa, M. Starr
.
, , ,
.
.
.
- : ,
. ,

(S. Rajapaksa, M. Starr, 2010).

2 .

- .
9 .
.

.
1.
, .
, , . -

- .

21

2.
-
.

.
3.

.
4.

.
5.





(A
A
Nat Healtth and Mediical Researcch Council).

In vitro

2
.



2.

.
6.

. ,

,
,




,
22

.
.
, .
7. .
.
8. .

.
-
.
.
9. - . -
, -
.
, ,
. - .
-
.

. Shigella
.
, ,
.
. Pneumococci Haemophilus influenza
, , .
Staphylococcus aureus , ,
. -
. -
.
- .
- National Guideline Clearinghouse, Medical Association Clinical
Practice Guidelines InfoBase, Centers for Health Evidence; Secretariat for Clinical Guidelines
and the Intercollegiate Guidelines Network (SIGN)
.

.

Cochrane collaboration .

.
- ,
.
23

8.
8.1.

.
8.2. ,
, -
.
8.3. - , ,
/ .
8.4. ,
. -
.
-
,
. CIOMS (
), -
-

(http://unesdoc.unesco.org/images/0014/001461/146180E.pdf) .
8.5. - , ,
.
- .


.

:
1. () ( : , ,
).
2. ,
3. / /- ,

4. :
4.1. ,
4.2. ,
4.3. ,
4.4. ,
4.5.
24

4.6. :
4.6.1.
4.6.2. ,
4.6.3. ,
4.6.4. , ( 1 ,
, , .
, , , , ,
)
4.6.5.
4.6.6.
4.6.7.
5.
5.1.
5.2.
8.6. 4
.
. 4 , ,

.:
8.6.1. :
( , / ,
)
8.6.2. :

8.6.3. :

8.6.4. :

8.7. - ,
.

( 3).
8.8.
( 4).
8.9. ,
( 5). -

,
. , - ,

25

.
, .
8.10.
.
8.11. -
. VSO, NLM
.
8.12. ,
, , ,
, ,
(, , , )
.

9.
1. A guide to the development, implementation and evaluation of clinical practice guidelines,
National Health and Medical Research Council, Australia, 1998
2. Geraets JJ, Geijer RM, Goudswaard AN. Dutch College of General Practitioners' practice
guideline on symptoms of the hand and wrist: a summary. Ned Tijdschr Geneeskd.
2010;154:A1795. Nederlands Huisartsen Genootschap, afd. Richtlijnontwikkeling en
Wetenschap, Utrecht, The Netherlands
3. Lckhoff C, Starr M. Minor head injuries in children - an approach to management. Aust Fam
Physician. 2010 May;39(5):284-7
4. Lugtenberg M, Burgers JS, Zegers-van Schaick JM, Westert GP. Guidelines on uncomplicated
urinary tract infections are difficult to follow: perceived barriers and suggested interventions.
BMC Fam Pract. 2010 Jun 28;11(1):51.
5. Rajapaksa S, Starr M., Meningococcal sepsis. Aust Fam Physician. 2010 May;39(5):276-8
6. Shah BR, Bhattacharyya O, Yu C, Mamdani M, Parsons JA, Straus SE, Zwarenstein M.
Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people
with type 2 diabetes: protocol for a cluster-randomized pragmatic trial. Trials. 2010 Apr
23;11:44
7. Tari Turner, Marie Misso, Claire Harris, Sally Green. Development of evidence based clinical
practice guidelines: comparing approaches. Implementation Science 2008, 3:45
8. The guidelines manual, National Institute for Health and Clinical Excellence, London, 2009
9. WHO Handbook for guideline development, 2008
26

10. Wilson MG, Jungner G. Principles and practice of screening for disease. Public Health Paper
34. Geneva. WHO. 1968

27

1.1 - ,
,

.
1.1. , ,
( : ,
, ,
, - ).
1.2. , (
,
,
,
).
1.3. , .
1.4.
( : - -
..)
1.5.
( : , ,
, , ).
. ()
2.1.
, ,
, . .
- ? ?
- ?
- ?
2.2. , ,
() .
2.3. , ,
. - ,
. ( 25- ..)
2.4. .
( : , , ,
, )
).

28

2.5. . (
, ,
..)
2.6.
2.7. - , , .
2.8. ( 1)
( 2), , ( 3) .
2.9. - , .
2.10. ,
, - ( 2), ,
( 3) .
2.11.-
.
2.12.-
.
2.13., -
.
2.14.- .
. () :
3.1. ()
.
3.1.1 ,

3.1.2. ( )
, (, )
.
3.2. ,
() .
3.3. - ,
.
3.4. - , , -
.
3.5. , , ,
, ,
.
(, ),

29

( , , ,
) .
3.6. , , ,
- , .
3.7. - ( - 4- )
4- (MNS-1-1:2006) , . -
. (:
.
.
, .)
3.8.-
.
. () :
4.1. ,
, , (
, , ).
4.2. -
.
4.3. .
4.4. ,
.
4.5.- , ,
.
4.6. , ,
, , .
4.7.
, , ,
.
4.8.

- ,
.

: , .
,
.


(O. Adnanes , 2010).

30

1.2 ,
1.
,
.
2.
.
3. ,
3
.
4. 1
, .
5. - , .
6. , 1
, ,
, C ,
, .
7. C , - ,
,
.
8.
, ,
.
9.
.

:
,
. , .

. , ,

(O. Adnanes , 2010).

31

1.3
.

1.1.

A ;

1.2 . :
.1. ( )
.2. , , , ;
1.3

1.4

-
. - ( :
, , ).
- , .
- .
-

A.

A.1. ( )
A.2. ( 10- )
A.3.
A.4.
A.5.
A.6.
A.7.
:
:
A.8.
A.9. , (
, , ).


( , , )
.1. , (, )

32

.1. ,
.1.
.1.
.2. , , (
, )
.1.
.2. ( ) ( : ,
)
.2.1. ( )
.3 ( )
.4. ,
.4.1.
.4.2. ()
.4.3.
.4.4.
.4.5. ( )
.4.6. : ( ); ; ( );
( ); ( ).
.4.7.
.4.8. ( )
.2.1. ( )
.2.2. ( )
.2.3. ( )
:.2
( , , ).
.

1.
2. ( )
3.

.

:
, .
- .
. -
, - - .

(O.
Adnanes

,
2010).
33

2 . , ,



,
,

,
,
- 2001 39


.
,
,

(
,
2006)
,
,

(
,
2006)
//

,
2010,
12
,
,

(
)



,
1
1.1
- WHO antenatal care randomized trial.

Manual for the implementation of the
new model, 2002-

, ,
.

,
/,
,

.

, .

,
,

(
,
, , -
2010)

,
,



.
.

-
.

, ,
.

1.2


1.3

34

(, ,
.)

,
, -
,


, ,

-
.
(
,
2006)

, 2005
, ,
,
.
,

(
,
2006)
1.4 /
,

.
,

(
, .
,
2006)
1.5
,
, ,
,

, .

), 2006
2
2.1

,
, ,

,
.
2.2

35


5
.

, ,


. -
.

, ,

,
,

,
.
2.3
, ,

,
.
2.4

, 2008

,
,
, ,
.

3-5

, 2005

,
,

,
MNS5349-2003

, 2006

//-

3
3.1
- .

,
,
, ,
.

.
,
,
, ,
.
3.2 //
- .

36

, 2010

2

-

, 2009

3.3
.
, ,
.

3.4

.
, ,

:
MNS 534940:2003
MNS 534942:2003
MNS
5349-41:2003
MNS
5349-16:2003

MNS 5349-45:2003
3.5

, ,

, 2010


2009

2010

-
.

3.6 ( , , , /, , , , . )


5
5.1
.
1.

,
.
2.

37

,
.271300.

2005

, 2008

, 2004

.
.

3.
4.
5.
6.
7.
8.

,

,
.
5.2
2-

.

.
2010

5.3
- -

,

. ,
, .

,
,
, ,
.
5.4

-
-
.

38

.
.

, , (, 2010)


,
1 (65%)
58% 0-4 , 75% 0-14 .
, .

.

2005, .77-80. .
.
.
,

.

MNS 6136-2010


2002-
.
.

,
MNS 6134-2010



2005-

.
.
-

,
,


MNS 6135-2010

2001, GOLD Initiative 2007-
.
.
, .

.

2005,
.451-456. .
.
,

39

.
.


,
MNS 5355-2004

(, )

2 (12%)
45% 0-4 , 53% 0-14 .
, .

.

2005, .109-126. .
.

: .
, .
, .
, .
, .
, .
.


MNS
5940-2008


.
.
,
.

.

.

MNS 5941-2008

MNS
5942-2008

, MNS 5665 2006

3 (10,5%)

-
,

.
MNS 5838-2008
,

.
.

40


2005,
.51-66.
,

.
.


MNS 5892-2008

.
-
.
.


.
.
4 (9,5%)
, ,

-
,
MNS 6099-2010

.
.

, MNS 58932008
/

,

2005, .129-160 ,
(
, ,
,
)

.
.
.

5 (3%)
5.1
1.
, .
2.
, .

.271-300. .
3.
.
2005
4.
5.
6.
7.
8.
,
,
.
5.2.

41

2005,
.51-66.
,

.
.
.
.


MNS 5892-2008

.
-
.
.


, MNS 5893 .
2008
.
5.3

.
.
MNS 5288-2003 .

.

, :
1.
2.
3.
4.
5.
6.
7.

(, , , , ):
:
:
: ,
:
:

42

3.

/ :____________________________ : ___________________________
2009 : _______________. 2010 :_______________

, ,


;
, ,

,
/

,
43

, ,

,
,

44

45





Erosio cornea




,

46





,
,


:

47

, ,

, ,

48

, ,

49

Carpal tunnel syndrome

50

(Chlamydial,
Mycoplasmal)

51

Myalgia epidemica

52

, ,

53


()

12

(Bartolin
abscess)

1.

54

2.

3.

(6
)

55

56

If other suggestions, please add:

Erythema nodosum

57

, ,

58

59

, , /;

, , ,

/ /

60

,
/

/
:

61

62

4. :

1.

, /
, ,
,

,
, , , ,
,


,
/ ,

2. justification.

.

. ,
. ,
, .
. ,

, ,
.
.

.

.
-
( , /
) .
.


63

. ,
, .
,
.
, , 24 .
/ . ,
.
3. .
1)
.
.
2) / .
3)
.
-
.
4) ,
.
.
5) ,
.
.
6) .
7) , - -
.
8) , ,
. 2
.
9)
.
10) -3 1-
1 .
11) VSO, NLM
-3 / .
4.
1. ,
.
2. , 2,
3
( , BNF-60, -
, ) .
64

5.
: _______________
6. () ( : , ,
).
7. ,
8. / /- ,

9. :
9.1. ,
9.2. ,
9.3. ,
9.4. ,
9.5.
9.6. :
9.6.1.
9.6.2. ,
9.6.3. ,
9.6.4. , ( 1 ,
, , .
, , , , ,
)
9.6.5.
9.6.6.
9.6.7.
10.
10.1.
10.2.
6. /
1.
.
2. -3 1-
7 .
7.
7.1. -3 1-
.
65

7.2.
7.2.1. -
7.2.2. - 1-
7.2.3. -

8. ,
1. -3 ,
.

66

5.

-
.
.
, , 3
. .

.
- ()-
- ()- , .

.
-
.
ALLHAT (The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trail)
Framingham /
, .
- - . - 50% -
. -
.
- .
24 , .
, , , ,
, .
.
() .
?
, ?
.
, - , 24 - ,
, ,
. NYHA (New York Heart Association)- , 2D

.
,
- .
- .
, ,
.
67

- ,
.
, ,
.
- - , ,

. 5

-
.

. ,

? - 50%
-


. 3-4
2
.

.

-
2 - 40-50%-
.
. ,


2-3



(ALLHAT, FRAMINGHAM).
4,5 ?
/-
.
?
.6

.


.

. 7


,

.
-
?
%
? %
?

68

.
.8

-


. ,

-


. -
2, 3-
.

- - ,

2009 679.44
.
, STEPS

-

-
.

. 11

-

,

-
.

- 24

,
. - -

. 12

. 12

-
.


.

.
? ? ?
2- ...

.

.

. 14

. 16

-
18-
,

( , ,

5 -
.
-

.
69

. 16

. 17

-
?

. 18

- -
.


.

.
50-75%-
.

-
.

- , ?
-
?

,
.

-
?

. -
- .

-
?

.

2D -

70


.
/

-
?

. 17

-
,

,
,
,
.

.

. 18

-
. -
. -
10-15%- .

. 18

.

. .
,

.
- .
-

?

. 21

.21

.
.
,
, ,
.

. 29

- - .
,
. ,
,
. -

-
.

71

.

-
.
-
.

.


- 2 3- ,
.
.
- ,
. -,
,
.
/
.
2
- ,
-
.
- ,
. .
-
. 50%

.
-
.
-
- !

72

:
0.9%- NaCl-
:

Dengue epidemic

DENGUE
HEMORRHAGIC
SHOCK

(, )


Ferrous sulfate

Mebendazole 100 mg
, < 2 : 1 2
3
,
Ferrous sulfate 60 mg
<1 :
1 5 :
6 12 : 1

Ferrous sulfate

73

ferrous sulfate + folic acid 60 + 0.25 mg


( 1 2 )

hlorphenamine 4 mg

: 1 3

74

: benzathine penicillin
G

Refer URGENTLY to hospital

: 1.2

()

Refer URGENTLY to hospital

Recurrent pain

YES

Giveibuprofen diclofenac aspirin

Refer, if worsening

Indomethacin

Refer

,
,

Ibuprofen diclofenac aspirin

75